Biopharma Sector Buzzes with Strategic Approvals, Key Partnerships, and Market Reactions Across Global Health Landscapes
admin The biopharmaceutical industry is currently a hotbed of activity, marked by significant regulatory milestones, innovative...
Biotech, Pharma & Cancer Drug Development
Roche’s Amylin-Targeting Obesity Drug Petrelintide Underperforms in Phase 2, Raising Questions on Market Competitiveness
Basel, Switzerland – Hopes for Roche’s amylin-targeting obesity drug, petrelintide, have been tempered following the...
Servier to Acquire Day One Biopharmaceuticals in Multibillion-Dollar Deal to Bolster Rare Oncology Portfolio
French pharmaceutical giant Servier has reached a definitive agreement to acquire Day One Biopharmaceuticals, a...
Controversial FDA Vaccines and Gene Therapies Chief Vinay Prasad Resigns Amid Tumultuous Tenure and Regulatory Disputes
Vinay Prasad, the polarizing figure who has led the Food and Drug Administration’s critical office...
Alnylam Forges Landmark $1.23 Billion Cardiovascular Discovery Alliance with Tenaya Therapeutics to Advance Disease-Modifying Therapies
Alnylam Pharmaceuticals, a leader in RNA interference (RNAi) therapeutics, has entered into a significant discovery...
FDA issues speedy approval to J&J’s Tecvayli-Darzalex combo
The pharmaceutical landscape for multiple myeloma has witnessed a significant acceleration with the U.S. Food...
